The role of carbonic anhydrase IX in hypoxia control in OSCC

Hypoxia-Specific Drug Tirapazamine Does Not Abrogate Hypoxic Tumor Cells in Combination Therapy with Irinotecan and Methylselenocysteine in Well-Differentiated Human Head and Neck Squamous Cell Carcinoma A253 Xenografts

(2015) Arup Bhattacharya et al.   NEOPLASIA

Hypoxia-inducible factors in OSCC

(2011) Mario Pérez-Sayáns et al.   CANCER LETTERS

Targeting Tumor Hypoxia: Suppression of Breast Tumor Growth and Metastasis by Novel Carbonic Anhydrase IX Inhibitors

(2011) Y. Lou et al.   CANCER RESEARCH

Hypoxia-induced autophagic response is associated with aggressive phenotype and elevated incidence of metastasis in orthotopic immunocompetent murine models of head and neck squamous cell carcinomas (HNSCC)

(2011) Nadarajah Vigneswaran et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Carbonic anhydrase inhibitors and activators for novel therapeutic applications

(2011) Claudiu T Supuran   Future Medicinal Chemistry

Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients

(2011) Alexander W Eckert et al.   HISTOPATHOLOGY

Prognostic significance of immunohistochemical biomarkers in oral squamous cell carcinoma

(2011) L.R. Oliveira et al.   INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

High Stromal Carbonic Anhydrase IX Expression Is Associated With Decreased Survival in p16-Negative Head-and-Neck Tumors

(2011) Nigel Brockton et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer Metastasis

(2011) Fabio Pacchiano et al.   JOURNAL OF MEDICINAL CHEMISTRY

Interfering with pH regulation in tumours as a therapeutic strategy

(2011) Dario Neri et al.   NATURE REVIEWS DRUG DISCOVERY

Carbonic anhydrase inhibitors

(2010) Claudiu T. Supuran   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1α

(2010) Sreenivasulu Chintala et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Hypoxia Inducible Factor 1  and Hypoxia Inducible Factor 2  Play Distinct and Functionally Overlapping Roles in Oral Squamous Cell Carcinoma

(2010) G.-q. Zhu et al.   CLINICAL CANCER RESEARCH

Carbonic Anhydrase IX as an Anticancer Therapy Target: Preclinical Evaluation of Internalizing Monoclonal Antibody Directed to Catalytic Domain

(2010) M. Zatovicova et al.   CURRENT PHARMACEUTICAL DESIGN

Identification of carbonic anhydrase 9 as a contributor to pingyangmycin-induced drug resistance in human tongue cancer cells

(2010) Guopei Zheng et al.   FEBS Journal

Use of multiple biological markers in radiotherapy-treated head and neck cancer

(2010) P Silva et al.   JOURNAL OF LARYNGOLOGY AND OTOLOGY

A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients

(2010) M. Siebels et al.   WORLD JOURNAL OF UROLOGY

The tumor antigens RHAMM and G250/CAIX are expressed in head and neck squamous cell carcinomas and elicit specific CD8+ T cell responses

(2009) Schmitt   INTERNATIONAL JOURNAL OF ONCOLOGY

The Relationship Between Human Papillomavirus Status and Other Molecular Prognostic Markers in Head and Neck Squamous Cell Carcinomas

(2009) Christina S. Kong et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Genetic and molecular alterations associated with oral squamous cell cancer (Review)

(2009) Pérez-Sayáns   ONCOLOGY REPORTS

The role of carbonic anhydrase IX as a molecular marker for transitional cell carcinoma of the bladder

(2008) Tobias Klatte et al.   BJU INTERNATIONAL

Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma

(2008) Sung-Weon Choi et al.   HUMAN PATHOLOGY

Carbonic anhydrases: novel therapeutic applications for inhibitors and activators

(2008) Claudiu T. Supuran   NATURE REVIEWS DRUG DISCOVERY

The prognostic value of hypoxia markers in T2-staged oral tongue cancer

(2008) Jong-Lyel Roh et al.   ORAL ONCOLOGY